Immune checkpoints and rheumatic diseases: what can cancer immunotherapy teach us?
- 19 August 2016
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Rheumatology
- Vol. 12 (10), 593-604
- https://doi.org/10.1038/nrrheum.2016.131
Abstract
No abstract availableThis publication has 113 references indexed in Scilit:
- Disease Tolerance as a Defense StrategyScience, 2012
- Genome-Wide Association Analysis of Autoantibody Positivity in Type 1 Diabetes CasesPLoS Genetics, 2011
- VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responsesThe Journal of Experimental Medicine, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility lociNature Genetics, 2010
- CD200R1 regulates the severity of arthritis but has minimal impact on the adaptive immune responseClinical and Experimental Immunology, 2010
- Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetesNature Genetics, 2009
- Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk lociNature Genetics, 2008
- FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunityNature Genetics, 2007
- Neutrophil Extracellular Traps Kill BacteriaScience, 2004